AI English summary of an SEC filing — figures as filed
The company said on October 10, 2025 its Board of Directors appointed Christopher DelOrefice as Chief Financial Officer, principal financial officer and principal accounting officer, effective December 5, 2025.
Key points
AI summaryThe company said on October 10, 2025 its Board of Directors appointed Christopher DelOrefice as Chief Financial Officer, principal financial officer and principal accounting officer, effective December 5, 2025.
The company said DelOrefice, 54, has served as Executive Vice President and Chief Financial Officer of Becton Dickinson & Company since September 2021, and prior to that spent over 20 years in financial leadership roles at Johnson & Johnson.
The company said it will pay DelOrefice an annual base salary of $980,000, and beginning in fiscal 2026 he will be eligible to receive an annual cash incentive with a target of 125% of base salary and a long-term incentive program with a target grant value of 450% of base salary.
The company said it will provide DelOrefice with a sign-on cash payment of $1,000,000 and restricted stock unit grants valued at $1,100,000 and $2,200,000 respectively. Christopher Lialios will transition from his role as Interim Chief Financial Officer back to Senior Vice President, Controller.
Summary
AI-writtenAnalysis scope · Filing body and confirmed press-release exhibitWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.
Ulta Beauty Names Christopher DelOrefice as Chief Financial Officer
The company said on October 10, 2025 its Board of Directors appointed Christopher DelOrefice as Chief Financial Officer, principal financial officer and principal accounting officer, effective December 5, 2025.
Source · Based on the filing body and exhibits
New Chief Financial Officer's Background
The company said DelOrefice, 54, has served as Executive Vice President and Chief Financial Officer of Becton Dickinson & Company since September 2021, and prior to that spent over 20 years in financial leadership roles at Johnson & Johnson.
Source · Based on the filing body and exhibits
Base Salary, Performance Incentive and Long-Term Incentive Terms
The company said it will pay DelOrefice an annual base salary of $980,000, and beginning in fiscal 2026 he will be eligible to receive an annual cash incentive with a target of 125% of base salary and a long-term incentive program with a target grant value of 450% of base salary.
Source · Based on the filing body and exhibits
Sign-On Compensation and Interim Chief Financial Officer's Return
The company said it will provide DelOrefice with a sign-on cash payment of $1,000,000 and restricted stock unit grants valued at $1,100,000 and $2,200,000 respectively. Christopher Lialios will transition from his role as Interim Chief Financial Officer back to Senior Vice President, Controller.
Source · Based on the filing body and exhibits
AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.
Original filing
The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.
Loading the filing text…